Strategy Asset Managers’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-210,973
| Closed | -$7.01M | – | 145 |
|
|
2017
Q2 | $7.01M | Buy |
210,973
+29,526
| +16% | +$981K | 1.44% | 26 |
|
|
2017
Q1 | $5.82M | Buy |
181,447
+7,269
| +4% | +$233K | 1.26% | 29 |
|
|
2016
Q4 | $6.01M | Buy |
174,178
+17,035
| +11% | +$588K | 1.32% | 29 |
|
|
2016
Q3 | $7.23M | Buy |
157,143
+112
| +0.1% | +$5.15K | 1.62% | 26 |
|
|
2016
Q2 | $7.89M | Buy |
157,031
+1,686
| +1% | +$84.7K | 1.79% | 24 |
|
|
2016
Q1 | $8.31M | Sell |
155,345
-9,197
| -6% | -$492K | 1.89% | 21 |
|
|
2015
Q4 | $10.8M | Sell |
164,542
-4,702
| -3% | -$309K | 2.46% | 9 |
|
|
2015
Q3 | $9.56M | Sell |
169,244
-3,061
| -2% | -$173K | 2.29% | 13 |
|
|
2015
Q2 | $10.2M | Sell |
172,305
-3,922
| -2% | -$232K | 2.27% | 14 |
|
|
2015
Q1 | $11M | Sell |
176,227
-9,287
| -5% | -$579K | 2.4% | 8 |
|
|
2014
Q4 | $10.7M | Sell |
185,514
-2,877
| -2% | -$165K | 2.24% | 13 |
|
|
2014
Q3 | $10.1M | Buy |
188,391
+227
| +0.1% | +$12.2K | 2.21% | 15 |
|
|
2014
Q2 | $9.86M | Sell |
188,164
-2,347
| -1% | -$123K | 2.1% | 19 |
|
|
2014
Q1 | $10.1M | Buy |
190,511
+3,585
| +2% | +$189K | 2.17% | 16 |
|
|
2013
Q4 | $7.49M | Buy |
186,926
+4,586
| +3% | +$184K | 1.64% | 26 |
|
|
2013
Q3 | $6.89M | Buy |
182,340
+2,401
| +1% | +$90.7K | 1.63% | 26 |
|
|
2013
Q2 | $7.05M | Buy |
+179,939
| New | +$7.05M | 1.68% | 25 |
|